根据国家统计局数据,2025年1-4月医药制造业收入增速仅0.8%,显著低于规模以上工业整体6.4%的增长水平。这一现象背后,既有行业周期性调整的阶段性特征,也暴露出结构性矛盾的长期积累。01主要原因剖析政策调控与支付体系的双重挤压。首先是集采常态化与价格下行压力,自2018年国家药品集采政策实施以来,药品价格持续下降。2024年第十批集采平均降幅达74.5%,部分品种降价超90%,直接压缩企业...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.